Andrew Perry, Chief Commercial Officer at G1 Therapeutics, Inc. (GTHX), sold 2,413 shares at $3.12 ($8K) on 2024-01-03, disclosed to the SEC on 2024-01-08.
Open-market sale of $8k GTHX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.12 | 379 | $1K | 15.7% |
| 2 | $3.12 | 2,034 | $6K | 84.3% |
| Total | $3.12 avg | 2,413 | $8K | 100% |
| Filing → |
| GTHX | SELL | 2023-07-07 | $870 | — | Filing → |
| GTHX | SELL | 2023-01-05 | $5K | — | Filing → |